NCT07213791 2026-04-17
FiREBOLT
Eli Lilly and Company
Phase 1 Recruiting
Clinical Trials
9 trialsNCT01013649 2026-02-23
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
National Cancer Institute (NCI)
Phase 3 Completed
NCT07262957 2025-12-22
PANENCA
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 4 Recruiting
NCT06519097 2025-11-13
Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3)
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Active not recruiting
NCT02070705 2025-07-31
DCE MRI in Patients With Pancreatic Cancer
OHSU Knight Cancer Institute
Phase NA Terminated
NCT04207944 2025-06-15
The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)
Duke University
Phase 2 Active not recruiting
NCT02757859 2025-05-20
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery
Thomas Jefferson University
Phase NA Recruiting
NCT06948474 2025-04-29
Dachengqi Decoction for Enhancing Early Gastrointestinal Recovery After Whipple Surgery
China-Japan Friendship Hospital
Phase NA Active not recruiting
NCT06162468 2025-04-23
Feasibility Trial of EUS-PCA in IPMN Pancreatic Cysts
University of Auckland, New Zealand
Phase NA Not yet recruiting